BRAINCHIP HOLDINGS LIMITED (BRN)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

BRN - BRAINCHIP HOLDINGS LIMITED

FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Software & Services
Debt/EBITDA: N/A
Index: ASX300 | ALL-ORDS | ALL-TECH

Brainchip Holdings is a holding company for its subsidiaries which provide neural computing technology and artificial neural networks through digital hardware and software. It operates in Australia and the US and has been a listed company since 2011.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.265

28 May
2024

-0.010

OPEN

$0.28

-3.64%

HIGH

$0.28

9,634,517

LOW

$0.26

OTHER COMPANIES IN THE SAME SECTOR
4DX . AT1 . BB1 . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CYC . EBR . EMV . EYE . FPH . IDX . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VTI .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx-2.4
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx0.3 M
Book Value Per Share xxxxxxxxxxxxxxx1.4
Net Operating Cash Flow xxxxxxxxxxxxxxx-26.4 M
Net Profit Margin xxxxxxxxxxxxxxx-12,448.51 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx-145.90 %
Return on Invested Capital xxxxxxxxxxxxxxx-136.24 %
Return on Assets xxxxxxxxxxxxxxx-119.86 %
Return on Equity xxxxxxxxxxxxxxx-145.90 %
Return on Total Capital xxxxxxxxxxxxxxx-128.51 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-26.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx2 M
Total Debt xxxxxxxxxxxxxxx2 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx21 M
Price To Book Value xxxxxxxxxxxxxxx12.36

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx0.2 M
Capex % of Sales xxxxxxxxxxxxxxx57.16 %
Cost of Goods Sold xxxxxxxxxxxxxxx1 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx41 M
Research & Development xxxxxxxxxxxxxxx9 M
Investments - Total xxxxxxxxxxxxxxx-

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

BRN STOCK CHART